These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31347997)

  • 1. Clonal spread of serotype 12F ST4846
    Ohkusu M; Takeuchi N; Ishiwada N; Ohkusu K
    J Med Microbiol; 2019 Sep; 68(9):1383-1390. PubMed ID: 31347997
    [No Abstract]   [Full Text] [Related]  

  • 2. Outbreak of invasive Streptococcus pneumoniae serotype 12F among a marginalized inner-city population in Winnipeg, Canada, 2009-2011.
    Schillberg E; Isaac M; Deng X; Peirano G; Wylie JL; Van Caeseele P; Pillai DR; Sinnock H; Mahmud SM
    Clin Infect Dis; 2014 Sep; 59(5):651-7. PubMed ID: 24842908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the local clonal spread of Streptococcus pneumoniae serotype 12F caused invasive pneumococcal diseases among children and adults.
    Nakanishi N; Yonezawa T; Tanaka S; Shirouzu Y; Naito Y; Ozaki A; Hama N; Ijichi A; Iwamoto T; Nomoto R
    J Infect Public Health; 2019; 12(6):867-872. PubMed ID: 31204116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017.
    Nakano S; Fujisawa T; Ito Y; Chang B; Matsumura Y; Yamamoto M; Suga S; Ohnishi M; Nagao M
    Emerg Infect Dis; 2020 Nov; 26(11):2660-2668. PubMed ID: 33079039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017.
    Nakano S; Fujisawa T; Ito Y; Chang B; Matsumura Y; Yamamoto M; Suga S; Ohnishi M; Nagao M
    Vaccine; 2020 Feb; 38(7):1818-1824. PubMed ID: 31882246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13.
    Redin A; Ciruela P; de Sevilla MF; Gomez-Bertomeu F; Gonzalez-Peris S; Benitez MA; Trujillo G; Diaz A; Jou E; Izquierdo C; Perez-Moreno MO; Moraga-Llop F; Olsina M; Vinado B; Sanfeliu E; Garcia A; Gonzalez-di Lauro S; Garcia-Garcia JJ; Dominguez A; Sa-Leao R; Muñoz-Almagro C;
    Microbiol Spectr; 2021 Dec; 9(3):e0115021. PubMed ID: 34878302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal characterisation of Streptococcus pneumoniae strains using MLST and MLVA - Can MLVA improve the characterisation?
    Kozáková J; Okonji Z; Musílek M
    Epidemiol Mikrobiol Imunol; 2020; 69(1):20-28. PubMed ID: 32326712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
    Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A;
    Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan.
    Shimbashi R; Chang B; Tanabe Y; Takeda H; Watanabe H; Kubota T; Kasahara K; Oshima K; Nishi J; Maruyama T; Kuronuma K; Fujita J; Ikuse T; Kinjo Y; Suzuki M; Kerdsin A; Shimada T; Fukusumi M; Tanaka-Taya K; Matsui T; Sunagawa T; Ohnishi M; Oishi K;
    PLoS One; 2019; 14(2):e0212418. PubMed ID: 30789928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain.
    González-Díaz A; Càmara J; Ercibengoa M; Cercenado E; Larrosa N; Quesada MD; Fontanals D; Cubero M; Marimón JM; Yuste J; Ardanuy C
    Clin Microbiol Infect; 2020 Jun; 26(6):753-759. PubMed ID: 31756452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal population in the era of vaccination: changes in composition and the relation to clinical outcomes.
    Elberse KE; Wagenvoort GH; Pluister GN; de Melker HE; Sanders EA; van der Ende A; Knol MJ
    Future Microbiol; 2016; 11(1):31-41. PubMed ID: 26673757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine.
    Elberse KE; van der Heide HG; Witteveen S; van de Pol I; Schot CS; van der Ende A; Berbers GA; Schouls LM
    Vaccine; 2012 Dec; 30(52):7644-51. PubMed ID: 22521844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel.
    Rokney A; Ben-Shimol S; Korenman Z; Porat N; Gorodnitzky Z; Givon-Lavi N; Ron M; Agmon V; Dagan R; Valinsky L
    Emerg Infect Dis; 2018 Mar; 24(3):453-461. PubMed ID: 29460732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain.
    Ludwig G; Garcia-Garcia S; Lanaspa M; Ciruela P; Esteva C; Fernandez de Sevilla M; Diaz-Conradi A; Marti C; Motje M; Galles C; Morta M; Izquierdo C; Moraga-Llop F; Campins M; Salleras L; Jane M; Dominguez A; Garcia-Garcia JJ; Muñoz-Almagro C;
    PLoS One; 2020; 15(2):e0228612. PubMed ID: 32027715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
    Kendall BA; Dascomb KK; Mehta RR; Stockmann C; Mason EO; Ampofo K; Pavia AT; Byington CL
    Vaccine; 2016 Jan; 34(4):474-478. PubMed ID: 26706276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic profiles and antimicrobial resistance of Streptococcus pneumoniae non-PCV10 serotype isolates recovered from meningitis cases in Salvador, Brazil.
    Azevedo J; Dos Anjos ES; Cordeiro SM; Dos Santos MS; Escobar EC; Lobo PR; Carvalho MDG; Reis MG; Reis JN; Campos LC
    J Med Microbiol; 2016 Oct; 65(10):1164-1170. PubMed ID: 27599851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-locus variable-number tandem-repeat analysis of Streptococcus pneumoniae and comparison with multiple loci sequence typing.
    van Cuyck H; Pichon B; Leroy P; Granger-Farbos A; Underwood A; Soullié B; Koeck JL
    BMC Microbiol; 2012 Oct; 12():241. PubMed ID: 23088225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotype evolution in Western Europe: perspectives on invasive pneumococcal diseases (IPD).
    Tin Tin Htar M; Morato Martínez J; Theilacker C; Schmitt HJ; Swerdlow D
    Expert Rev Vaccines; 2019 Nov; 18(11):1145-1155. PubMed ID: 31682762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.